SCHEMBL22855065

SCHEMBL22855065

c1ccc(-c2cc(-c3ccc(-c4ccc(-c5c6ccccc6c(-c6ccccc6-c6cccc7ccccc67)c6ccccc56)c5oc6ccccc6c45)cc3)ccc2-c2c3ccccc3c(-c3ccc(-c4ccccc4)c4c3oc3ccccc34)c3ccccc23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 4/20 0.38
▸ CA1 P00915 4/20 0.38
▸ CA2 P00918 4/20 0.38
▸ CA9 Q16790 4/20 0.38
▸ CDC14B O60729 2/20 0.37
▸ CDC14A Q9UNH5 2/20 0.37
▸ SLC6A9 P48067 1/20 0.37
▸ ALOX5 P09917 2/20 0.36
▸ PIM1 P11309 1/20 0.35
▸ CSNK2A2 P19784 1/20 0.35
▸ CSNK2B P67870 1/20 0.35
▸ PIM3 Q86V86 1/20 0.35
▸ PIM2 Q9P1W9 1/20 0.35
▸ MAPT P10636 2/20 0.35
▸ ATM Q13315 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ APAF1 O14727 1/20 0.35
▸ NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22854866 0.93 CDC14B (0.41) CDC14BCDC14AALOX5MAPTATM
SCHEMBL22088294 0.90 ALOX5 (0.39) CA12CA1CA2CA9CDC14B
SCHEMBL24106895 0.90 ALOX5 (0.39) CA12CA1CA2CA9CDC14B
SCHEMBL22707189 0.88 CDC14B (0.44) CDC14BCDC14AALOX5MAPTATM
SCHEMBL24648412 0.87 CDC14B (0.41) CA12CA1CA2CA9CDC14B
SCHEMBL22854811 0.87 CDC14B (0.41) CA12CA1CA2CA9CDC14B
SCHEMBL23504606 0.86 ALOX5 (0.39) CA12CA1CA2CA9CDC14B
SCHEMBL23504699 0.86 ALOX5 (0.39) CA12CA1CA2CA9CDC14B
SCHEMBL25104194 0.85 ALOX5 (0.39) CA12CA1CA2CA9CDC14B
SCHEMBL23504605 0.85 CDC14B (0.39) CA12CA1CA2CA9CDC14B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200411771-A1 ORGANIC LIGHT-EMITTING DEVICE LG CHEM, LTD. (KR) 2020-12-31 — — US disclosed
US-20160326086-A1 4-HYDROXYBUTYRIC ACID ANALOGS SUN PHARMACEUTICAL INDUSTRIES, INC. 2016-11-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160326086-A1 4-HYDROXYBUTYRIC ACID ANALOGS HCRTR2, HCRTR1, HTR2B CA12 2467/4885CA1 1490/4885CA2 351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback